Pfizer completely divested its remaining ownership stake in Zoetis through a massive stock-for-stock exchange offer, making Zoetis an entirely independent, publicly traded corporation. Although Zoetis originated as the animal health subsidiary of Pfizer and shares deep historical roots in pharmaceutical development, it has operated as a standalone global enterprise listed on the New York Stock Exchange under the ticker symbol ZTS.